President and Chief Medical Officer Tracy George, MD, worked with ARUP’s PharmaDX and Clinical Trials group to create the central pathology review offering used in clinical trials for AYVAKIT. The new precision therapy for advanced systemic mastocytosis recently earned approval from the U.S. Food and Drug Administration. |
July 2, 2021 | The FDA recently approved a new precision therapy developed by Blueprint Medicines for adults with advanced systemic mastocytosis, a rare and potentially fatal hematologic malignancy. |
Adam Barker, PhD, has been named ARUP’s first chief scientific officer. He moves into the role after having spent four years as director of Research and Development. |
July 1, 2021 |
ARUP Appoints Adam Barker, PhD, to Lead Its New Technologies Group Adam Barker, PhD, has been appointed as ARUP’s chief scientific officer, a role in which he will lead the newly formed New Technologies Group. |
A former employee chats with CEO Sherrie L. Perkins, MD, PhD (center), during a reception on June 24, 2021, to celebrate Perkins’ retirement after 31 years at ARUP and the University of Utah. |
June 30, 2021 |
ARUP Welcomes New CEO with Sherrie L. Perkins’ Retirement ARUP Laboratories today bid farewell to CEO Sherrie L. Perkins, MD, PhD, who retired after 31 years with the company and the University of Utah Department of Pathology. Perkins called her retirement “bittersweet” in a companywide message in which she thanked employees. |
New Infectious Diseases Society of America guidelines, authored by a panel led by ARUP’s Kimberly Hanson, MD, MHS, describe the benefits and limitations of COVID-19 rapid antigen testing. The expert panel suggests that standard nucleic acid amplification testing should be used instead of rapid antigen tests in most circumstances when possible. |
June 22, 2021 |
ARUP Expert Leads IDSA Panel That Authored New COVID-19 Antigen Testing Guidelines Rapid antigen testing has been used widely during the COVID-19 pandemic to determine infection status in settings such as schools or workplaces, but its role has changed as the pandemic has evolved. |
June 18, 2021 |
Premier Inc. Honors ARUP with Prestigious Supplier Legacy Award ARUP announced that it has received the 2021 Supplier Legacy Award from Premier Inc., a leading healthcare improvement company. |
|
ARUP Chief Operations Officer Jonathan Genzen, MD, PhD (left), joined CEO Sherrie L. Perkins, MD, PhD, President Andy Theurer, and Board Chairman Peter Jensen, MD, on June 15, 2021, to cut a ceremonial ribbon to officially open ARUP’s new state-of-the-art laboratory facility in University of Utah Research Park. |
June 15, 2021 |
ARUP Celebrates the Opening of a New State-of-the-Art Laboratory Facility in Salt Lake City ARUP Laboratories, one of the nation’s largest reference laboratories, held a ribbon cutting ceremony to officially open its new four-story, 220,000-square-foot laboratory facility in Salt Lake City. |